Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W Bergmann

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 14, 2017
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registryMartin W Bergmann, Timothy R Betts, Horst Sievert, et al.
JACC. Cardiovascular Interventions|June 8, 2019
Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMANLars Søndergaard, Yam-Hong Wong, Vivek Y Reddy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 2, 2023
Sex-related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registryChristina Paitazoglou, Ingo Eitel, Thomas Stiermaier, et al.
Stem Cells (Dayton, Ohio)|May 9, 2014
Erythropoietin responsive cardiomyogenic cells contribute to heart repair post myocardial infarctionMaria Patapia Zafiriou, Claudia Noack, Bernhard Unsöld, et al.
Journal of Cardiovascular Electrophysiology|May 4, 2018
Incidence of pericardial effusion after left atrial appendage closure: The impact of underlying heart rhythm-Data from the EWOLUTION studyBoris Schmidt, Timothy R Betts, Horst Sievert, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 23, 2012
Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trialChristian-H Heeger, Kai Jaquet, Holger Thiele, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 10, 2018
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers studyMartin W Bergmann, Hüseyin Ince, Stephan Kische, et al.
The Journal of Invasive Cardiology|May 2, 2022
True Efficacy of LAA Closure: Patient Outcomes on Long-term Single-Antiplatelet or No Therapy: Insights From the EWOLUTION RegistryChristina Paitazoglou, Martin W Bergmann, Hüseyin Ince, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiationLaura C Zelarayán, Claudia Noack, Belaid Sekkali, et al.
European Journal of Heart Failure|February 22, 2019
Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)Christina Paitazoglou, Martin W Bergmann, Bojan Vrtovec, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 14, 2017
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registryMartin W Bergmann, Timothy R Betts, Horst Sievert, et al.
JACC. Cardiovascular Interventions|June 8, 2019
Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMANLars Søndergaard, Yam-Hong Wong, Vivek Y Reddy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 2, 2023
Sex-related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registryChristina Paitazoglou, Ingo Eitel, Thomas Stiermaier, et al.
Stem Cells (Dayton, Ohio)|May 9, 2014
Erythropoietin responsive cardiomyogenic cells contribute to heart repair post myocardial infarctionMaria Patapia Zafiriou, Claudia Noack, Bernhard Unsöld, et al.
Journal of Cardiovascular Electrophysiology|May 4, 2018
Incidence of pericardial effusion after left atrial appendage closure: The impact of underlying heart rhythm-Data from the EWOLUTION studyBoris Schmidt, Timothy R Betts, Horst Sievert, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 23, 2012
Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trialChristian-H Heeger, Kai Jaquet, Holger Thiele, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 10, 2018
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers studyMartin W Bergmann, Hüseyin Ince, Stephan Kische, et al.
The Journal of Invasive Cardiology|May 2, 2022
True Efficacy of LAA Closure: Patient Outcomes on Long-term Single-Antiplatelet or No Therapy: Insights From the EWOLUTION RegistryChristina Paitazoglou, Martin W Bergmann, Hüseyin Ince, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiationLaura C Zelarayán, Claudia Noack, Belaid Sekkali, et al.
European Journal of Heart Failure|February 22, 2019
Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)Christina Paitazoglou, Martin W Bergmann, Bojan Vrtovec, et al.
Pageof 10